Atlas Technologies

Raising $1M for accelerating revenues for building LLMs to drive our BTB SaaS business serving Pharmaceutical companies

Facebook Twitter LinkedIn

Developed a Social Listening tool that captures conversations between Digital Opinion Leaders in the Healthcare space. This information is used by Pharmaceutical companies to understand the drivers of interest in their brands.

Today, tech moves so fast that there is limited time and differentiation to create a long-term advantage. We believe we have created a space different from "social listening" by capturing digital conversations between Digital Opinion Leaders (DOLs) with a large share of voice, not a large share of followers. This seems counterintuitive, but the negative commentary customarily filtered out by other tools is captured and categorized into usable data for most regulated markets. We not only have patents on this process, but most of the tools that attempt to do social listening would have to be entirely rebuilt to make their application able to accomplish this. 

In the pharmaceutical industry, market research can be a significant financial burden. However, with our technology, we can provide the equivalent of a research panel with thousands of panelists and continuous participation, all at just a fraction, 10%, of the cost of traditional market research. This cost-effectiveness is a significant advantage, making our proposition highly attractive.

We seek $1M in seed funding for 10% of the post-money valuation. We have over $1M in current revenues and a $2.7M ARR against current SaaS subscription renewals.

Demo Video

Ready to Ask For Funding for your company?

Post a Funding Request

Atlas Technologies is no longer seeking funding.